Josefin Ahnström Selected Research

factor X Nottingham

1/2020

Partial rescue of naturally occurring active site factor X variants through decreased inhibition by tissue factor pathway inhibitor and antithrombin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Josefin Ahnström Research Topics

Disease

5	Thrombosis (Thrombus) 02/2024 - 05/2014
3	Hemorrhage 01/2024 - 01/2020
3	Atherosclerosis 03/2012 - 03/2010
2	Hemophilia A (Haemophilia) 07/2022 - 10/2019
1	Wounds and Injuries (Trauma) 01/2024
1	Neoplasms (Cancer) 01/2023
1	Aneurysm (Aneurysms) 01/2023
1	Thromboinflammation 07/2022
1	Thrombocytopenia (Thrombopenia) 07/2022
1	Venous Thromboembolism 07/2022
1	Autolysis 11/2021
1	Pulmonary Arterial Hypertension 11/2021
1	Osteoarthritis 01/2021
1	Protein S Deficiency (Deficiency, Protein S) 11/2020
1	Venous Thrombosis (Deep-Vein Thrombosis) 11/2020
1	Ischemia 07/2015
1	Necrosis 07/2015
1	Purpura 07/2015
1	Buruli Ulcer 07/2015
1	Type 2 Diabetes Mellitus (MODY) 11/2010
1	Diabetes Mellitus 11/2010
1	Chronic Limb-Threatening Ischemia 04/2010
1	Abdominal Aortic Aneurysm 03/2010
1	Cardiovascular Diseases (Cardiovascular Disease) 03/2009
1	Coronary Disease (Coronary Heart Disease) 09/2008

Drug/Important Bio-Agent (IBA)

3	Apolipoproteins MIBA 03/2012 - 09/2008
2	FibrinIBA 02/2024 - 07/2015
2	Hemostatics (Antihemorrhagics)IBA 01/2024 - 11/2020
2	ThrombospondinsIBA 01/2023 - 11/2021
2	Metalloproteases (Metalloproteinases)IBA 01/2023 - 11/2021
2	Peptide Hydrolases (Proteases)FDA Link 01/2023 - 11/2021
2	DisintegrinsIBA 01/2023 - 11/2021
2	Protein SIBA 01/2021 - 11/2020
2	Apolipoproteins AIBA 04/2010 - 03/2010
2	ApolipoproteinsIBA 04/2010 - 03/2010
1	VaccinesIBA 07/2022
1	ADAMTS ProteinsIBA 11/2021
1	aggrecanaseIBA 01/2021
1	factor X NottinghamIBA 01/2020
1	SerpinsIBA 10/2019
1	Prothrombin (Factor II)IBA 09/2019
1	Thrombin FDA Link 09/2019
1	salicylhydroxamic acid (SHAM)IBA 09/2019
1	Fibrinogen (Factor I)FDA Link 09/2019
1	Apoprotein(a) (Apolipoprotein (a))IBA 09/2019
1	Lipoproteins (Lipoprotein)IBA 09/2019
1	fibrin fragment D (D-dimer)IBA 09/2019
1	von Willebrand FactorIBA 09/2019
1	PlasminogenIBA 09/2019
1	MacrolidesIBA 07/2015
1	ExotoxinsIBA 07/2015
1	AnticoagulantsIBA 07/2015
1	ThrombomodulinIBA 07/2015
1	mycolactoneIBA 07/2015
1	oxidized low density lipoproteinIBA 03/2012
1	Fibric Acids (Fibrates)IBA 11/2010
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 11/2010
1	CholesterolIBA 03/2009

Therapy/Procedure

2	Lasers (Laser) 02/2024 - 05/2014
1	Blood Component Removal (Apheresis) 09/2019